Immunomodulation in Adult Epilepsy: The Role of IVIG

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S0317167100015304PMID 22931698
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Imaging Inflammation in a Patient with Epilepsy Due to Focal Cortical Dysplasia

  2013cited by this paper
• VGKC antibodies in pediatric encephalitis presenting with status epilepticus

  2011cited by this paper
• Brain Infiltration of Leukocytes Contributes to the Pathophysiology of Temporal Lobe Epilepsy

  2011cited by this paper
• Epilepsy and sleep.

  2011cited by this paper
• IL-1 receptor/Toll-like receptor signaling in infection, inflammation, stress and neurodegeneration couples hyperexcitability and seizures.

  2011cited by this paper
• The role of inflammation in epilepsy

  2011cited by this paper
• Hashimoto's encephalopathy: a long-lasting remission induced by intravenous immunoglobulins.

  2011cited by this paper
• Intravenous immunoglobulins for epilepsy.

  2011cited by this paper
• Inflammation in epilepsy: Clinical observations

  2011cited by this paper
• Mechanisms of epileptogenesis and potential treatment targets.

  2011cited by this paper
• Inflammation and prevention of epileptogenesis.

  2011cited by this paper
• Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis.

  2011cited by this paper
• Refractory Epilepsy Associated With Microglial Activation

  2011cited by this paper
• Super‐refractory status epilepticus: An approach to therapy in this difficult clinical situation

  2011cited by this paper
• Autoantibodies and epilepsy

  2011cited by this paper
• The growing recognition of immunotherapy-responsive seizure disorders with autoantibodies to specific neuronal proteins

  2010cited by this paper
• Prevention or Modification of Epileptogenesis after Brain Insults: Experimental Approaches and Translational Research

  2010cited by this paper
• Management of voltage-gated potassium channel antibody disorders.

  2010cited by this paper
• Minozac Treatment Prevents Increased Seizure Susceptibility in a Mouse “Two-Hit” Model of Closed Skull Traumatic Brain Injury and Electroconvulsive Shock-Induced Seizures

  2010cited by this paper
• Evaluation of the innate and adaptive immunity in type I and type II focal cortical dysplasias

  2010cited by this paper
• Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease

  2010cited by this paper
• An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis

  2010cited by this paper
• The COX-2 inhibitor parecoxib is neuroprotective but not antiepileptogenic in the pilocarpine model of temporal lobe epilepsy.

  2010cited by this paper
• Paediatric Hashimoto encephalopathy, refractory epilepsy and immunoglobulin treatment – unusual case report and review of the literature

  2010cited by this paper
• Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression?

  2010cited by this paper
• Effect of intravenous immunoglobulin treatment on brain interferon-gamma and interleukin-6 levels in a rat kindling model.

  2010cited by this paper
• Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature.

  2010cited by this paper
• Successful Treatment of Acute Autoimmune Limbic Encephalitis With Negative VGKC and NMDAR Antibodies

  2009cited by this paper
• Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy

  2009cited by this paper
• Diagnostic value of N-methyl-D-aspartate receptor antibodies in women with new-onset epilepsy.

  2009cited by this paper
• Epilepsy in later life.

  2009cited by this paper
• Landau‐Kleffner syndrome and CSWS syndrome: Treatment with intravenous immunoglobulins

  2009cited by this paper
• Status epilepticus due to paraneoplastic and nonparaneoplastic encephalitides

  2009cited by this paper
• Sleep loss activates cellular inflammatory signaling.

  2008cited by this paper
• Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex.

  2008cited by this paper
• Paraneoplastic syndromes of the CNS.

  2008cited by this paper
• Increased spontaneous activity of a network of hippocampal neurons in culture caused by suppression of inhibitory potentials mediated by anti-gad antibodies

  2008cited by this paper
• Treatment of status epilepticus

  2008cited by this paper
• Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

  2008cited by this paper
• Guidelines on the use of intravenous immune globulin for neurologic conditions.

  2007cited by this paper
• Limbic encephalitis: a cause of temporal lobe epilepsy with onset in adult life.

  2007cited by this paper
• Drug Insight: the use of intravenous immunoglobulin in neurology—therapeutic considerations and practical issues

  2007cited by this paper
• Intravenous Immunoglobulins in Refractory Childhood‐Onset Epilepsy: Effects on Seizure Frequency, EEG Activity, and Cerebrospinal Fluid Cytokine Profile

  2007cited by this paper
• The epidemiology of convulsive and nonconvulsive status epilepticus

  2007cited by this paper
• Immunoglobulines intraveineuses et insuffisance rénale : mécanisme et prévention

  2007cited by this paper
• Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy

  2007cited by this paper
• [Intravenous immunoglobulins and acute renal failure: mechanism and prevention].

  2007cited by this paper
• Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

  2006cited by this paper
• Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes

  2006cited by this paper
• Cyclooxygenase-2 inhibitor, celecoxib, inhibits the altered hippocampal neurogenesis with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.

  2006cited by this paper
• Literature review, case report, and expert discussion of prolonged refractory status epilepticus

  2006cited by this paper
• Antibodies to voltage-gated potassium and calcium channels in epilepsy.

  2006cited by this paper
• The role of inflammation in CNS injury and disease

  2006cited by this paper
• Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates.

  2005cited by this paper
• Causal Links between Brain Cytokines and Experimental Febrile Convulsions in the Rat

  2005cited by this paper
• Serum antibodies in epilepsy and seizure-associated disorders

  2005cited by this paper
• Neuropsychiatry and behavioural neurology explained

  2005cited by this paper
• Epilepsy and the immune system: is there a link?

  2005cited by this paper
• Brain Inflammation in Epilepsy: Experimental and Clinical Evidence

  2005cited by this paper
• Treatment of idiopathic west and lennox-gastaut syndromes by intravenous administration of human polyvalent immunoglobulins

  2004cited by this paper
• Regulation of IL-6 system in cerebrospinal fluid and serum compartments by seizures: the effect of seizure type and duration.

  2004cited by this paper
• Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis.

  2004cited by this paper
• Chronic epilepsy and cognition: A longitudinal study in temporal lobe epilepsy

  2003cited by this paper
• Progressive loss of cardiac sympathetic innervation in Parkinson's disease

  2002cited by this paper
• Stress and the inflammatory response: a review of neurogenic inflammation.

  2002cited by this paper
• Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy.

  2002cited by this paper
• Clinical Research : Newly Diagnosed Unprovoked Epileptic Seizures : Presentation at Diagnosis in CAROLE Study

  2001cited by this paper
• Incidence of Status Epilepticus in Adults in Germany: A Prospective, Population‐Based Study

  2001cited by this paper
• Positive response to immunomodulatory therapy in an adult patient with Rasmussen’s encephalitis

  2001cited by this paper
• Early identification of refractory epilepsy.

  2000cited by this paper
• Status Epilepticus: Risk Factors and Complications

  2000cited by this paper
• Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: case report and literature review of intravenous immunoglobulin-related thrombotic complications.

  2000cited by this paper
• IGIV in Neurology — Evidence and Recommendations

  1999cited by this paper
• Mechanism of Action of Intravenous Immunoglobulin and Therapeutic Considerations in the Treatment of Autoimmune Neurologic Diseases

  1998cited by this paper
• Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature.

  1998cited by this paper
• Delineation of the Proinflammatory Cytokine Cascade in Fever Induction a

  1998cited by this paper
• Prevalence and signification of antinuclear and anticardiolipin antibodies in patients with epilepsy.

  1997cited by this paper
• MATTERS ARISING

  1995cited by this paper
• Epidemiology of Status Epilepticus

  1995cited by this paper
• Adult first generalized seizure: etiology, biological tests, EEG, CT scan, in an ED.

  1995cited by this paper
• Treatment of refractory epilepsy with intravenous immunoglobulins

  1994cited by this paper
• Immunoglobulin treatment in human and experimental epilepsy.

  1994cited by this paper
• Medical treatment of Rasmussen's syndrome (chronic encephalitis and epilepsy)

  1994cited by this paper
• Immunoglobulin treatment in epilepsy, a review of the literature.

  1994cited by this paper
• Aseptic Meningitis Associated with High-Dose Intravenous Immunoglobulin Therapy: Frequency and Risk Factors

  1994cited by this paper
• Remission of Seizures and Predictors of Intractability in Long‐Term Follow‐Up

  1993cited by this paper
• Intravenous high‐dose gammaglobulins for intractable childhood epilepsy

  1993cited by this paper
• Intravenous Immunoglobulin: A Single-Blind Trial in Children with Lennox-Gastaut Syndrome

  1990cited by this paper
• Intravenous immunoglobulin: a review.

  1989cited by this paper
• Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA.

  1986cited by this paper
• Antiepileptic effects of globulin-N, an intact human immunoglobulin and its tissue-distribution in kindled cats.

  1984cited by this paper
• Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents.

  1983cited by this paper
• [The treatment of epileptic encephalopathies with gamma globulin in children (author's transl)].

  1977cited by this paper
• The permeability of the blood—brain barrier during electrically induced seizures in man

  1977cited by this paper
• Origin of seizures in elderly patients.

  1977cited by this paper
• The origin and turnover rates of cerebrospinal fluid albumin and gamma-globulin in man.

  1970cited by this paper

• Fremanezumab and its isotype slow propagation rate and shorten cortical recovery period but do not prevent occurrence of cortical spreading depression in rats with compromised blood brain barrier.

  2019cites this paper
• Update on the use of immunoglobulin in human disease: A review of evidence

  2017cites this paper
• Intavenous immunoglobulin for the management of intractable epilepsy in a boy.

  2017cites this paper
• Intravenous immunoglobulin in the treatment of neurologic disorders

  2016cites this paper
• Inflammatory mediators in human epilepsy: A systematic review and meta-analysis.

  2016cites this paper